David Hartnett, Vice President of Economic Development, Bioscience - Health IT Industry Development for the Metro Atlanta Chamber (MAC) and David Perryman Chief Operating Officer of DRIVE, are the recipients of the 2014 Georgia Bio Industry Growth Awards.
According to a release, the Industry Growth Awards are the highest honors bestowed each year by Georgia Bio (GaBio). They recognize individuals in the public and private sectors who have made extraordinary contributions to the growth of Georgia's life sciences industry. David Hartnett is the recipient from the public sector, David Perryman from the private sector.
David Hartnett is being honored for his leadership of the bioscience and health IT arm of the Metro Atlanta Chamber's economic development division and for being instrumental in recruiting and advancing the bioscience and medtech industries in the Georgia.
Prior to joining the Chamber, Hartnett served as the president and CEO of Maco Pharma a privately held medical device company headquartered in Lille, France. Prior to Maco Pharma, Hartnett was president and CEO of SteriFx Corp., a specialty chemical company, contracted by U.S. Department of Defense (DARPA). Prior to SteriFx, he was the executive vice president of the North American headquarters of Given Imaging. Under his leadership the company commercialized the "PillCam" a platform disposable video capsule. Hartnett helped to raise close to $30 million in a private placement for corporate infrastructure development and product commercialization prior to the company going public in 2001.
In addition, his leadership and support of numerous organizations including the Innovation Crescent Regional Partnership, Technology Association of Georgia, Southeastern Medical Device Association, Venture Atlanta, the Atlanta Science Festival and Georgia Bio have helped to create a stronger economic development front and enhance collaboration throughout Georgia.
David Perryman is being honored as a successful entrepreneur, attorney and leader of Georgia's bioscience community. He is currently COO of Drug Innovation Ventures at Emory (DRIVE), an innovative not-for profit biotechnology company that seeks to change the model for the development of university based therapeutics.
Prior to DRIVE, David was the CEO and a founder of Zirus, Inc., a biotech company focused on the host genetics of infectious diseases. Prior to Zirus, he was head of the biotechnology patent group at the intellectual property firm, Needle & Rosenberg, as it grew to national prominence. Perryman has co-managed the strategy of several successful multi-million dollar biotech patent litigations, was a co- founder and an advisor for Georgia Venture Partners, Inc., and was a founder and a board member of Maxia Pharmaceuticals, as well as several other biotechnology companies. His contributions have made a transformative difference within Georgia's life science industry.
Hartnett and Perryman will be honored at the Georgia Bio Annual Awards Dinner, January 23, 6 pm to 9 pm, at the Atlanta Fox Theater.
((Comments on this story may be sent to firstname.lastname@example.org))